IL102346A0 - Cysteine depleted il-6 muteins - Google Patents

Cysteine depleted il-6 muteins

Info

Publication number
IL102346A0
IL102346A0 IL102346A IL10234692A IL102346A0 IL 102346 A0 IL102346 A0 IL 102346A0 IL 102346 A IL102346 A IL 102346A IL 10234692 A IL10234692 A IL 10234692A IL 102346 A0 IL102346 A0 IL 102346A0
Authority
IL
Israel
Prior art keywords
positions
muteins
native
occur
cysteine residues
Prior art date
Application number
IL102346A
Other languages
English (en)
Original Assignee
Imclone Systems Inc
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imclone Systems Inc, Univ North Carolina filed Critical Imclone Systems Inc
Publication of IL102346A0 publication Critical patent/IL102346A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL102346A 1991-07-02 1992-06-29 Cysteine depleted il-6 muteins IL102346A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72469891A 1991-07-02 1991-07-02

Publications (1)

Publication Number Publication Date
IL102346A0 true IL102346A0 (en) 1993-01-14

Family

ID=24911511

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102346A IL102346A0 (en) 1991-07-02 1992-06-29 Cysteine depleted il-6 muteins

Country Status (18)

Country Link
US (2) US5359034A (es)
EP (1) EP0592566B1 (es)
JP (1) JPH07502162A (es)
AT (1) ATE183775T1 (es)
AU (1) AU2308992A (es)
CA (1) CA2111327A1 (es)
DE (1) DE69229862T2 (es)
DK (1) DK0592566T3 (es)
ES (1) ES2138973T3 (es)
GR (1) GR3031927T3 (es)
IE (1) IE922153A1 (es)
IL (1) IL102346A0 (es)
MX (1) MX9203879A (es)
NZ (1) NZ243290A (es)
PT (1) PT100651A (es)
TW (1) TW275066B (es)
WO (1) WO1993001212A1 (es)
ZA (1) ZA924674B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003492A1 (en) * 1992-08-06 1994-02-17 The University Of Melbourne Interleukin-6 variants and uses therefor
JPH09505721A (ja) * 1992-10-20 1997-06-10 シータス オンコロジー コーポレイション インターロイキン６レセプターアンタゴニスト
US5641657A (en) * 1994-05-19 1997-06-24 Human Genome Sciences, Inc. DNA encoding an interleukin-6 splice variant
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6124448A (en) * 1994-08-17 2000-09-26 The Rockfeller University Nucleic acid primers and probes for the mammalian OB gene
EP0832220A1 (en) * 1995-06-07 1998-04-01 Amgen Inc. Ob protein compositions and method
US5861500A (en) * 1996-07-25 1999-01-19 The Trustees Of Columbia University In The City Of New York Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof
US5854398A (en) * 1996-07-25 1998-12-29 The Trustees Of Columbia University In The City Of New York Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof
EP0966480A2 (en) 1997-01-30 1999-12-29 The University Of Virginia Patent Foundation Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor
WO2005072340A2 (en) * 2004-01-27 2005-08-11 Compugen Ltd. Novel polynucleotides encoding polypeptides and methods using same
WO2006072954A2 (en) * 2005-01-05 2006-07-13 Compugen Ltd. Novel il-6 polynucleotides encoding variant il-6 polypeptides and methods using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0585957A1 (en) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
CA2004261A1 (en) * 1988-12-01 1990-06-01 Charles T. Tackney Synthetic interleukin-6

Also Published As

Publication number Publication date
CA2111327A1 (en) 1993-01-21
EP0592566A1 (en) 1994-04-20
AU2308992A (en) 1993-02-11
MX9203879A (es) 1994-01-31
DE69229862T2 (de) 2000-01-13
IE922153A1 (en) 1993-01-13
DE69229862D1 (de) 1999-09-30
ZA924674B (en) 1993-04-28
DK0592566T3 (da) 1999-12-13
ES2138973T3 (es) 2000-02-01
NZ243290A (en) 1995-04-27
WO1993001212A1 (en) 1993-01-21
PT100651A (pt) 1993-09-30
US5545537A (en) 1996-08-13
JPH07502162A (ja) 1995-03-09
EP0592566A4 (en) 1995-05-24
GR3031927T3 (en) 2000-03-31
EP0592566B1 (en) 1999-08-25
US5359034A (en) 1994-10-25
ATE183775T1 (de) 1999-09-15
TW275066B (es) 1996-05-01

Similar Documents

Publication Publication Date Title
GR3031927T3 (en) Cysteine depleted il-6 muteins
CA2346997A1 (en) Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
MY101887A (en) A novel human physiologically active polypeptide.
MY102806A (en) Human interleukin-3 and muteins thereof
SE9002589L (sv) Neutrofil-aktiverande peptid-2
GB8821785D0 (en) Peptide compounds
EP0336779A3 (en) Polypeptides stabilized by covalent hydrogen bond replacements
WO1988006625A3 (en) Arginine-depleted human tumor necrosis factor
EP0212912A3 (en) Calcitonin analogs with c-therminal d-amino acid substituents
CA2056467A1 (en) Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
IL82654A0 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
DK59198A (da) Præparat omfattende rekombinant produceret aminoterminusacetyleret human sur fibroblastvækstfaktor, fremgangsmåde til frems